FR2024M - Use of isoxazole derivatives for the treatment of mental illnesses and in particular of nervous breakdowns. - Google Patents

Use of isoxazole derivatives for the treatment of mental illnesses and in particular of nervous breakdowns.

Info

Publication number
FR2024M
FR2024M FR886501A FR886501A FR2024M FR 2024 M FR2024 M FR 2024M FR 886501 A FR886501 A FR 886501A FR 886501 A FR886501 A FR 886501A FR 2024 M FR2024 M FR 2024M
Authority
FR
France
Prior art keywords
treatment
mental illnesses
isoxazole derivatives
nervous breakdowns
breakdowns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR886501A
Other languages
French (fr)
Inventor
Hideo Kano
Ikuo Adachi
Ryonosuke Kido
Kenjiro Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of FR2024M publication Critical patent/FR2024M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FR886501A 1961-02-01 1962-01-31 Use of isoxazole derivatives for the treatment of mental illnesses and in particular of nervous breakdowns. Active FR2024M (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP319161 1961-02-01

Publications (1)

Publication Number Publication Date
FR2024M true FR2024M (en) 1963-09-23

Family

ID=11550496

Family Applications (1)

Application Number Title Priority Date Filing Date
FR886501A Active FR2024M (en) 1961-02-01 1962-01-31 Use of isoxazole derivatives for the treatment of mental illnesses and in particular of nervous breakdowns.

Country Status (2)

Country Link
FR (1) FR2024M (en)
GB (1) GB938420A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009330A1 (en) * 1987-05-20 1988-12-01 Zambon Group S.P.A. Isoxazoles with nootropic activity

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988009330A1 (en) * 1987-05-20 1988-12-01 Zambon Group S.P.A. Isoxazoles with nootropic activity

Also Published As

Publication number Publication date
GB938420A (en) 1963-10-02

Similar Documents

Publication Publication Date Title
BE613590A (en) Improvement in the treatment of waste gases.
FR2024M (en) Use of isoxazole derivatives for the treatment of mental illnesses and in particular of nervous breakdowns.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
BE605476A (en) Veterinary composition for the treatment of enterohepatitis in turkeys
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1489M (en) 4,4 'substituted diphenlysulfones and pharmaceutical preparations thereof for the treatment of viral diseases.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1857M (en) New drug in particular for the treatment of diseases of viral origin.
FR2467M (en) New drug in particular for the treatment of neuro-depressive states and anxiety psychoses.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR2014M (en) Medicament for the treatment of eczema and other skin diseases, in particular conditions causing baldness.
FR1783M (en) Stabilized forms of dimethylcarboxy-alkylsulfonium used, in particular, for the treatment of hepatic and vascular disorders.
FR1303023A (en) Advanced device for water treatment and other applications
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR2817M (en) Combinations of drugs for the treatment of mental disorders.
FR1284M (en) Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.
FR1780M (en) New drug in particular for the treatment of disorders of protein anabolism.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR2458M (en) New drug in particular for the treatment of depressive states or anxiety.
FR153M (en) New isopropylated drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR139M (en) New drug for the treatment of migraines of hepatic origin and in general hepatic disorders.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR2789M (en) New drug in particular for the treatment of hypercholesterolemia and the resulting disorders.